The NHS is looking to understand the usefulness of pharmacogenomics in primary care

There is growing understanding that the effectiveness and safety of many regularly prescribed medications can be influenced by common genetic changes. This is a concept known as pharmacogenomics.

Despite this awareness, testing for these genetic changes is rarely done in the UK prior to prescribing. One reason for this is because, to date, it has been very difficult to get this genetic information to prescribers quickly enough and in a useful format, so it can be used on a routine basis.

The NHS England PROGRESS Study looks to address these issues. This study will develop and test the process by which genetic information can be tested and returned to GPs in General Practice, quickly and accurately.

{{ failureMessage }}

Start by entering your email address below if you’re interested in taking part.

{{ errors.email[0] }}

Participant benefits

  • By taking part in this study, you will have access to a new clinical service which is being evaluated for future use in the NHS.
  • By taking part, genetic information will be generated for you which may indicate a safer or more effective medicine. This information will also be stored in your GP record to be used in any future prescribing for you, by your GP.
  • You can also opt to receive a copy of your own pharmacogenetic information for future reference. Your involvement in the study will allow researchers to evaluate whether this service is suitable and can be provided for all patients in the future.
The Progress Study
loading...